Teva Pharmaceutical Industries (TEVA) P/S ratio

P/S ratio today
2.9×

Teva Pharmaceutical Industries (TEVA) trades at 2.9× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 2.1×. That is 39.6% higher than the 1.5× of fiscal 2024. Figures as of 18 Nov 2026, 09:52 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
2.9×
P/S ratio, fiscal 2025
2.1×
Change on fiscal 2024
+39.6%
Highest on record
7.8×fiscal 2016
Lowest on record
0.6×fiscal 2021
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Teva Pharmaceutical Industries P/S ratio, in more detail

Today's figure is 36.6% above the fiscal 2025 year-end.

Across the 19 fiscal year-ends on record (2007–2025), the highest was 7.8× in fiscal 2016 and the lowest 0.6× in fiscal 2021. Today's P/S ratio is higher than at 68% of the 19 fiscal year-ends on record; their median is 1.7×.

History · 19 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Teva Pharmaceutical Industries P/S ratio, year by year

Teva Pharmaceutical Industries (TEVA) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today2.9×—$42.62—
20252.1× 39.6% up$31.21$14.84
20241.5× 104.4% up$22.04$14.63
20230.7× 8.7% up$10.44$14.16
20220.7× 21.5% up$9.12$13.45
20210.6× 12.0% down$8.01$14.34
20200.6× 0.2% up$9.65$15.21
20190.6× 26.5% down$9.80$15.48
20180.9× 2.2% down$15.42$17.90
20170.9× 88.7% down$18.95$21.51
20167.8× 169.5% up$36.25$4.66
20152.9× 18.6% up$65.64$22.75
20142.4× 45.1% up$57.51$23.63
20131.7× 4.5% up$40.08$23.90
20121.6× 18.5% down$37.34$23.27
20112.0× 33.9% down$40.36$20.51
20103.0× 4.6% down$52.13$17.50
20093.1× 0.8% down$56.18$17.99
20083.1× 23.2% down$42.57$13.52
20074.1×—$46.48$11.33

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of Teva Pharmaceutical Industries and comparable companies
CompanyP/S ratio
Medline MDLN1.7×
Humana HUM0.4×
Agilent Technologies A7.0×
Teva Pharmaceutical Industries TEVA2.9×
BeOne Medicines ONC8.8×
Waters WAT27.9×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on TEVA

Teva Pharmaceutical Industries, figure by figure

Teva Pharmaceutical Industries (TEVA) overview: price, valuation and scorecardAll health care companies by market value

Teva Pharmaceutical Industries P/S ratio: questions and answers

What is Teva Pharmaceutical Industries's P/S ratio?

Teva Pharmaceutical Industries (TEVA) trades at 2.9× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 2.1×. That is 39.6% higher than the 1.5× of fiscal 2024.

Is Teva Pharmaceutical Industries's P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 68% of the 19 fiscal year-ends on record; their median is 1.7×.

What are the highest and lowest P/S ratio figures on record for Teva Pharmaceutical Industries?

Across the 19 fiscal year-ends on record (2007–2025), the highest was 7.8× in fiscal 2016 and the lowest 0.6× in fiscal 2021.

How is Teva Pharmaceutical Industries's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Teva Pharmaceutical Industries it is on record here for 19 fiscal years, 2007 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Teva Pharmaceutical Industries (TEVA) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/TEVA/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.